GeneThera Current Valuation vs. Net Income

GTHR Stock  USD 0.0001  0.00  0.00%   
Based on the key profitability measurements obtained from GeneThera's financial statements, GeneThera may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess GeneThera's ability to earn profits and add value for shareholders.
For GeneThera profitability analysis, we use financial ratios and fundamental drivers that measure the ability of GeneThera to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well GeneThera utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between GeneThera's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of GeneThera over time as well as its relative position and ranking within its peers.
  
Check out Risk vs Return Analysis.
Please note, there is a significant difference between GeneThera's value and its price as these two are different measures arrived at by different means. Investors typically determine if GeneThera is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GeneThera's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

GeneThera Net Income vs. Current Valuation Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining GeneThera's current stock value. Our valuation model uses many indicators to compare GeneThera value to that of its competitors to determine the firm's financial worth.
GeneThera is rated as one of the top companies in current valuation category among its peers. It also is one of the top stocks in net income category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the GeneThera's earnings, one of the primary drivers of an investment's value.

GeneThera Current Valuation vs. Competition

GeneThera is rated as one of the top companies in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Biotechnology industry is currently estimated at about 11.88 Billion. GeneThera adds roughly 1.44 Million in current valuation claiming only tiny portion of stocks in Biotechnology industry.

GeneThera Net Income vs. Current Valuation

Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

GeneThera

Enterprise Value

 = 

Market Cap + Debt

-

Cash

 = 
1.44 M
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

GeneThera

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

 = 
(1.01 M)
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.

GeneThera Net Income Comparison

GeneThera is currently under evaluation in net income category among its peers.

GeneThera Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in GeneThera, profitability is also one of the essential criteria for including it into their portfolios because, without profit, GeneThera will eventually generate negative long term returns. The profitability progress is the general direction of GeneThera's change in net profit over the period of time. It can combine multiple indicators of GeneThera, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
GeneThera, Inc., a biotechnology company, develops molecular assays and therapeutics for the detection and treatment of zoonotic diseases. The companys Molecular RoboticAI Platform and Therapeutic strategy is designed to prevent the spread of disease from animals and allow to better control of zoonotic infectious agents. Genethera operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 2 people.

GeneThera Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on GeneThera. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of GeneThera position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the GeneThera's important profitability drivers and their relationship over time.

Learn to be your own money manager

Our tools can tell you how much better you can do entering a position in GeneThera without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Idea Breakdown Now

   

Idea Breakdown

Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
All  Next Launch Module

Use Investing Themes to Complement your GeneThera position

In addition to having GeneThera in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Tech Funds Thematic Idea Now

Tech Funds
Tech Funds Theme
Funds or Etfs that invest in companies involved in research, development, testing, or distribution of technologically based goods and services. The Tech Funds theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Tech Funds Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for GeneThera Pink Sheet Analysis

When running GeneThera's price analysis, check to measure GeneThera's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneThera is operating at the current time. Most of GeneThera's value examination focuses on studying past and present price action to predict the probability of GeneThera's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneThera's price. Additionally, you may evaluate how the addition of GeneThera to your portfolios can decrease your overall portfolio volatility.